Clinical Trials
Dry Eye Disease

Disease/ Subspecialty:

Dry Eye Disease

Principal Investigator:

Stephen C. Pflugfelder, M.D.

Contact:

email DryEye-Trials@bcm.tmc.edu
or call (713)798-4125

Enrollment:

No

Sponsor:

Alcon

Title:

A phase II, dose-ranging study to evaluate rimexolone 0.0005%, 0.05% and 0.1% ophthalmic suspensions versus rimexolone vehicle in relieving the ocular signs and symptoms of dry eye in patients with autoimmune connective tissue disease.

IRB Protocol #:

H-13144
home | contact us | bcm public | bcm intranet | privacy notices
about us:
faculty | background | history | facilities
patient care:
meet our physicians | request an appointment | prescription refill | financial policy | directions/ find us | amenities | patient education | FAQ
referring physicians:
meet our physicians | request an appointment | request for information | grand rounds schedule | continuing medical education | FAQ
education:
grand rounds schedule | medical students | resident applicants | fellowship applicants
research/ clinical trials:
cataract | dry eye disease | genetics | glaucoma | hiv/ aids | laser vision correction | macular degeneration | pediatric eye disorders | retinal disorders
giving | links

©2001 Department of Ophthalmology - Baylor College of Medicine
http://www.bayloreye.org/trials/dryeye.html